Literature DB >> 12210728

Fanconi anemia protein complex is a novel target of the IKK signalsome.

Tetsuya Otsuki1, David B Young, Dennis T Sasaki, Matthew P Pando, Jianwu Li, Anthony Manning, Merl Hoekstra, Maureen E Hoatlin, Frank Mercurio, Johnson M Liu.   

Abstract

Fanconi anemia (FA), a genetic disorder predisposing to aplastic anemia and cancer, is characterized by hypersensitivity to DNA-damaging agents and oxidative stress. Five of the cloned FA proteins (FANCA, FANCC, FANCE, FANCF, FANCG) appear to be involved in a common functional pathway that is required for the monoubiquitination of a sixth gene product, FANCD2. Here, we report that FANCA associates with the IkappaB kinase (IKK) signalsome via interaction with IKK2. Components of the FANCA complex undergo rapid, stimulus-dependent changes in phosphorylation, which are blocked by kinase-inactive IKK2 (IKK2 K > M). When exposed to mitomycin C, cells expressing IKK2 K > M develop a cell cycle abnormality characteristic of FA. Thus, FANCA may function to recruit IKK2, thus providing the cell a means of rapidly responding to stress. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210728     DOI: 10.1002/jcb.10270

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Fanconi anemia proteins and their interacting partners: a molecular puzzle.

Authors:  Tagrid Kaddar; Madeleine Carreau
Journal:  Anemia       Date:  2012-03-29

2.  Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia.

Authors:  Sudit S Mukhopadhyay; Kathryn S Leung; M John Hicks; Philip J Hastings; Hagop Youssoufian; Sharon E Plon
Journal:  J Cell Biol       Date:  2006-10-23       Impact factor: 10.539

Review 3.  A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.

Authors:  Ponnumony John Solomon; Priya Margaret; Ramya Rajendran; Revathy Ramalingam; Godfred A Menezes; Alph S Shirley; Seung Jun Lee; Moon-Woo Seong; Sung Sup Park; Dodam Seol; Soo Hyun Seo
Journal:  Ital J Pediatr       Date:  2015-05-08       Impact factor: 2.638

4.  Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients.

Authors:  Snehal Shabrish; Madhura Kelkar; Niranjan Chavan; Mukesh Desai; Umair Bargir; Maya Gupta; Priti Mehta; Akanksha Chichra; Chandrakala S; Prasad Taur; Vinay Saxena; Babu Rao Vundinti; Manisha Madkaikar
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

5.  Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.

Authors:  Igor Landais; Sanne Hiddingh; Matthew McCarroll; Chao Yang; Aiming Sun; Mitchell S Turker; James P Snyder; Maureen E Hoatlin
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

6.  AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.

Authors:  Min Jeong Chun; Sunshin Kim; Soo Kyung Hwang; Bong Sub Kim; Hyoun Geun Kim; Hae In Choi; Jong Heon Kim; Sung Ho Goh; Chang-Hun Lee
Journal:  Oncotarget       Date:  2016-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.